Compare ARRY & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARRY | ETON |
|---|---|---|
| Founded | 1989 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 975.3M | 872.7M |
| IPO Year | 2020 | 2018 |
| Metric | ARRY | ETON |
|---|---|---|
| Price | $5.68 | $45.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 3 |
| Target Price | $10.21 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 6.4M | 523.9K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.56 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $1,284,141,000.00 | $79,950,000.00 |
| Revenue This Year | $15.72 | $40.90 |
| Revenue Next Year | $8.08 | $47.23 |
| P/E Ratio | ★ N/A | $928.40 |
| Revenue Growth | 40.22 | ★ 104.94 |
| 52 Week Low | $4.77 | $13.99 |
| 52 Week High | $12.23 | $50.18 |
| Indicator | ARRY | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 60.91 |
| Support Level | N/A | $15.77 |
| Resistance Level | $8.45 | N/A |
| Average True Range (ATR) | 0.34 | 2.78 |
| MACD | -0.00 | 0.24 |
| Stochastic Oscillator | 38.19 | 60.28 |
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.